{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:23:34Z","timestamp":1766168614597,"version":"3.48.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":47,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"NIHR Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.phro.2025.100867","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:59:52Z","timestamp":1763639992000},"page":"100867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Using three-dimensional equieffective dose mapping to audit a methodology for calculating permitted doses for head and neck reirradiation"],"prefix":"10.1016","volume":"36","author":[{"given":"David","family":"Nash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Muscat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelmis M.","family":"Thiong\u2019o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana Vasquez","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony L.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2025.100867_b0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ctrv.2017.07.003","article-title":"Treatment of late sequelae after radiotherapy for head and neck cancer","volume":"59","author":"Strojan","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.phro.2025.100867_b0010","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1634\/theoncologist.2009-0289","article-title":"Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis","volume":"15","author":"Pulte","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.phro.2025.100867_b0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13014-023-02342-0","article-title":"Advancements of radiotherapy for recurrent head and neck cancer in modern era","volume":"18","author":"Zhang","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2025.100867_b0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejmp.2019.01.004","article-title":"Second re-irradiation: a delicate balance between safety and efficacy","volume":"58","author":"Nieder","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2025.100867_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2025.03.002","article-title":"Reirradiation special medical physics consultations: lessons learned from nearly 3000 courses of treatment","author":"Paradis","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2025.100867_b0030","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ijrobp.2006.07.1383","article-title":"Update of human spinal cord reirradiation tolerance based on additional data from 38 patients","volume":"66","author":"Nieder","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2025.100867_b0035","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ijrobp.2004.06.016","article-title":"Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients","volume":"61","author":"Nieder","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2025.100867_b0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00066-002-0948-1","article-title":"Re-irradiation of the human spinal cord","volume":"178","author":"Sminia","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.phro.2025.100867_b0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1748-717X-8-287","article-title":"Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma","volume":"8","author":"Niyazi","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2025.100867_b0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijrobp.2010.08.021","article-title":"Reirradiation human spinal cord tolerance for stereotactic body radiotherapy","volume":"82","author":"Sahgal","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2025.100867_b0055","unstructured":"RTTQA. BRIOChe: Radiotherapy outlining, planning, treatment delivery and QA guidelines. 2024."},{"key":"10.1016\/j.phro.2025.100867_b0060","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2025.100867_b0065","article-title":"Feasibility and flexibility of a novel multi-dose level avoidance reirradiation technical methodology in recurrent head and neck cancer","volume":"10","author":"Hague","year":"2024","journal-title":"BJR Case Rep"},{"key":"10.1016\/j.phro.2025.100867_b0070","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejmp.2022.06.015","article-title":"The geometric and dosimetric effect of algorithm choice on propagated contours from CT to cone beam CTs","volume":"100","author":"Nash","year":"2022","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2025.100867_b0075","doi-asserted-by":"crossref","first-page":"S3525","DOI":"10.1016\/S0167-8140(24)01460-9","article-title":"965: Individualised dose mapping uncertainty estimation for head and neck cancer re-irradiation","volume":"194","author":"Thiong\u2019o","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100867_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.semradonc.2025.02.009","article-title":"Reirradiation for locally recurrent head and neck cancer: state-of-the-art and future directions","volume":"35","author":"Phan","year":"2025","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.phro.2025.100867_b0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.adro.2019.05.007","article-title":"The special medical physics consult process for reirradiation patients","volume":"4","author":"Paradis","year":"2019","journal-title":"Adv Radiat Oncol"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631625001721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631625001721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:19:55Z","timestamp":1766168395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631625001721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":17,"alternative-id":["S2405631625001721"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2025.100867","relation":{},"ISSN":["2405-6316"],"issn-type":[{"type":"print","value":"2405-6316"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using three-dimensional equieffective dose mapping to audit a methodology for calculating permitted doses for head and neck reirradiation","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2025.100867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100867"}}